HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Glucose tolerance and lipid profile in longterm exogenous subclinical hyperthyroidism and the effects of restoration of euthyroidism, a randomised controlled trial.

AbstractOBJECTIVE:
The impact of prolonged subclinical hyperthyroidism on glucose and lipid metabolism is unclear. Therefore, we evaluated glucose and lipid metabolism in patients with differentiated thyroid carcinoma (DTC) on TSH suppressive thyroxine therapy as a model for subclinical hyperthyroidism and investigated whether restoration to euthyroidism affects metabolism.
DESIGN:
We performed a prospective, single-blinded, placebo-controlled, randomised trial of 6 months duration with 2 parallel groups.
PATIENTS:
Twenty-five subjects with a history of differentiated thyroid carcinoma with > 10 years TSH-suppressive therapy with l-thyroxine completed the study. l-thyroxine dose was replaced by study medication containing l-thyroxine or l-thyroxine plus placebo. Medication was titrated to establish continuation of TSH suppression (low-TSH group, 13 patients) and euthyroidism (euthyroidism group, 12 patients).
MEASUREMENTS:
We evaluated glucose metabolism by glucose tolerance test and HOMA (IR) and lipid metabolism by lipid profile. In addition, we measured plasma concentrations of glucoregulatory hormones.
RESULTS:
At baseline, glucose tolerance, HOMA (IR), lipid profile and plasma concentrations of glucoregulatory hormones were within the normal range. No significant differences between the low TSH and euthyroidism group were observed. After 6 months, neither glucose nor lipid metabolism in the low TSH group were different from baseline values.
CONCLUSION:
In summary, glucose and lipid metabolism in patients with DTC and long-term subclinical hyperthyroidism in general are not affected. Restoration of euthyroidism in general does not affect glucose and lipid metabolism.
AuthorsK A Heemstra, J W A Smit, C F A Eustatia-Rutten, A C Heijboer, M Frölich, J A Romijn, E P M Corssmit
JournalClinical endocrinology (Clin Endocrinol (Oxf)) Vol. 65 Issue 6 Pg. 737-44 (Dec 2006) ISSN: 0300-0664 [Print] England
PMID17121524 (Publication Type: Journal Article, Randomized Controlled Trial)
Chemical References
  • Insulin
  • Lipids
  • Thyrotropin
  • Thyroxine
Topics
  • Adult
  • Carcinoma (blood, drug therapy, surgery)
  • Female
  • Glucose Intolerance
  • Humans
  • Hyperthyroidism (blood)
  • Insulin (blood)
  • Lipids (blood)
  • Male
  • Middle Aged
  • Prospective Studies
  • Single-Blind Method
  • Thyroid Neoplasms (blood, drug therapy, surgery)
  • Thyroidectomy
  • Thyrotropin (blood)
  • Thyroxine (blood, therapeutic use)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: